Clinically available pharmacogenomics tests

D. A. Flockhart, Todd Skaar, D. S. Berlin, T. E. Klein, A. T. Nguyen

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The development of robust and clinically valuable pharmacogenomic tests has been anticipated to be one of the first tangible results of the Human Genome Project. Despite both obvious and unanticipated obstacles, a number of tests have now become available in various practice settings. Lessons can be learned from examination of these tests, the evidence that has catalyzed their use, their value to prescribers, and their merit as tools for personalizing therapeutics.

Original languageEnglish
Pages (from-to)109-113
Number of pages5
JournalClinical Pharmacology and Therapeutics
Volume86
Issue number1
DOIs
StatePublished - Jul 2009

Fingerprint

Human Genome Project
Pharmacogenetics
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Flockhart, D. A., Skaar, T., Berlin, D. S., Klein, T. E., & Nguyen, A. T. (2009). Clinically available pharmacogenomics tests. Clinical Pharmacology and Therapeutics, 86(1), 109-113. https://doi.org/10.1038/clpt.2009.39

Clinically available pharmacogenomics tests. / Flockhart, D. A.; Skaar, Todd; Berlin, D. S.; Klein, T. E.; Nguyen, A. T.

In: Clinical Pharmacology and Therapeutics, Vol. 86, No. 1, 07.2009, p. 109-113.

Research output: Contribution to journalArticle

Flockhart, DA, Skaar, T, Berlin, DS, Klein, TE & Nguyen, AT 2009, 'Clinically available pharmacogenomics tests', Clinical Pharmacology and Therapeutics, vol. 86, no. 1, pp. 109-113. https://doi.org/10.1038/clpt.2009.39
Flockhart, D. A. ; Skaar, Todd ; Berlin, D. S. ; Klein, T. E. ; Nguyen, A. T. / Clinically available pharmacogenomics tests. In: Clinical Pharmacology and Therapeutics. 2009 ; Vol. 86, No. 1. pp. 109-113.
@article{aad9f5cc60864b88af8dcd7056611560,
title = "Clinically available pharmacogenomics tests",
abstract = "The development of robust and clinically valuable pharmacogenomic tests has been anticipated to be one of the first tangible results of the Human Genome Project. Despite both obvious and unanticipated obstacles, a number of tests have now become available in various practice settings. Lessons can be learned from examination of these tests, the evidence that has catalyzed their use, their value to prescribers, and their merit as tools for personalizing therapeutics.",
author = "Flockhart, {D. A.} and Todd Skaar and Berlin, {D. S.} and Klein, {T. E.} and Nguyen, {A. T.}",
year = "2009",
month = "7",
doi = "10.1038/clpt.2009.39",
language = "English",
volume = "86",
pages = "109--113",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Clinically available pharmacogenomics tests

AU - Flockhart, D. A.

AU - Skaar, Todd

AU - Berlin, D. S.

AU - Klein, T. E.

AU - Nguyen, A. T.

PY - 2009/7

Y1 - 2009/7

N2 - The development of robust and clinically valuable pharmacogenomic tests has been anticipated to be one of the first tangible results of the Human Genome Project. Despite both obvious and unanticipated obstacles, a number of tests have now become available in various practice settings. Lessons can be learned from examination of these tests, the evidence that has catalyzed their use, their value to prescribers, and their merit as tools for personalizing therapeutics.

AB - The development of robust and clinically valuable pharmacogenomic tests has been anticipated to be one of the first tangible results of the Human Genome Project. Despite both obvious and unanticipated obstacles, a number of tests have now become available in various practice settings. Lessons can be learned from examination of these tests, the evidence that has catalyzed their use, their value to prescribers, and their merit as tools for personalizing therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=67650642313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650642313&partnerID=8YFLogxK

U2 - 10.1038/clpt.2009.39

DO - 10.1038/clpt.2009.39

M3 - Article

VL - 86

SP - 109

EP - 113

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 1

ER -